{"transactions":[{"id":3618650,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-04T23:29:44.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 48 equal monthly installments following the date of grant."}],"balance_after":51000,"derivative":{"exercise_price":8.02,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":51000},"source":{"system":"sec-edgar","filing":"0001209191-19-015927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119015927/doc4.xml","form_type":"4"}},{"id":3618649,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-04T23:29:44.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":657,"price":8.03,"value":5275.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":32021,"source":{"system":"sec-edgar","filing":"0001209191-19-015927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119015927/doc4.xml","form_type":"4"}},{"id":3618648,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-03-04T23:29:44.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date."}],"balance_after":32678,"source":{"system":"sec-edgar","filing":"0001209191-19-015927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119015927/doc4.xml","form_type":"4"}},{"id":3667904,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-08T22:27:41.000Z","date":"2019-02-06","kind":"sale","acquired":false,"shares":2580,"price":7.71,"value":19891.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":24178,"source":{"system":"sec-edgar","filing":"0001209191-19-008675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119008675/doc4.xml","form_type":"4"}},{"id":3667903,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-08T22:27:41.000Z","date":"2019-02-06","kind":"sale","acquired":false,"shares":198,"price":8.15,"value":1613.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary trades by the Reporting Person."}],"balance_after":26758,"source":{"system":"sec-edgar","filing":"0001209191-19-008675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119008675/doc4.xml","form_type":"4"}},{"id":3839831,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-18T00:28:00.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the total number of shares underlying this option shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020."}],"balance_after":12500,"derivative":{"exercise_price":8.58,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-18-047548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919118047548/doc4.xml","form_type":"4"}},{"id":3839830,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-18T00:28:00.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of the restricted stock units payable solely in common stock that vest as follows: 1/3rd of the total number of shares shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,706 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2018."}],"balance_after":26956,"source":{"system":"sec-edgar","filing":"0001209191-18-047548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919118047548/doc4.xml","form_type":"4"}},{"id":4019669,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-03T00:26:08.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest as to 25% after one year following the grant date, and the remainder will vest in equal monthly installments over the following three years."}],"balance_after":37500,"derivative":{"exercise_price":16.95,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001209191-18-016039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919118016039/doc4.xml","form_type":"4"}},{"id":4019668,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-03T00:26:08.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001209191-18-016039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919118016039/doc4.xml","form_type":"4"}},{"id":4120862,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-12-27T19:07:02.000Z","date":"2017-12-22","kind":"exercise","acquired":false,"shares":3529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date."}],"balance_after":33273,"derivative":{"exercise_price":4.21,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":3529},"source":{"system":"sec-edgar","filing":"0001209191-17-067392","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117067392/doc4.xml","form_type":"4"}},{"id":4120861,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-27T19:07:02.000Z","date":"2017-12-22","kind":"sale","acquired":false,"shares":3529,"price":20.5,"value":72344.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-067392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117067392/doc4.xml","form_type":"4"}},{"id":4120860,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-27T19:07:02.000Z","date":"2017-12-22","kind":"exercise","acquired":true,"shares":3529,"price":4.21,"value":14857.09,"ownership":{"direct":true},"balance_after":3529,"source":{"system":"sec-edgar","filing":"0001209191-17-067392","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117067392/doc4.xml","form_type":"4"}},{"id":4188935,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-10-10T23:04:09.000Z","date":"2017-10-05","kind":"exercise","acquired":false,"shares":2017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date."}],"balance_after":36802,"derivative":{"exercise_price":4.21,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":2017},"source":{"system":"sec-edgar","filing":"0001209191-17-056551","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117056551/doc4.xml","form_type":"4"}},{"id":4188934,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:04:09.000Z","date":"2017-10-05","kind":"sale","acquired":false,"shares":2017,"price":19,"value":38323.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-056551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117056551/doc4.xml","form_type":"4"}},{"id":4188933,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-10T23:04:09.000Z","date":"2017-10-05","kind":"exercise","acquired":true,"shares":2017,"price":4.21,"value":8491.57,"ownership":{"direct":true},"balance_after":2017,"source":{"system":"sec-edgar","filing":"0001209191-17-056551","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117056551/doc4.xml","form_type":"4"}},{"id":4211464,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-12T23:50:26.000Z","date":"2017-09-12","kind":"sale","acquired":false,"shares":3687,"price":14.3078,"value":52752.8586,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 1,822 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 8, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold at prices ranging from $14.251 to $14.3443. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-052501","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117052501/doc4.xml","form_type":"4"}},{"id":4221469,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-08-30T23:08:52.000Z","date":"2017-08-29","kind":"exercise","acquired":false,"shares":1512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date."}],"balance_after":38819,"derivative":{"exercise_price":4.21,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":1512},"source":{"system":"sec-edgar","filing":"0001209191-17-050815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117050815/doc4.xml","form_type":"4"}},{"id":4221468,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-08-30T23:08:52.000Z","date":"2017-08-29","kind":"sale","acquired":false,"shares":1512,"price":17,"value":25704.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017."}],"balance_after":1865,"source":{"system":"sec-edgar","filing":"0001209191-17-050815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117050815/doc4.xml","form_type":"4"}},{"id":4221467,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-08-30T23:08:52.000Z","date":"2017-08-29","kind":"exercise","acquired":true,"shares":1512,"price":4.21,"value":6365.52,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,865 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2017."}],"balance_after":3377,"source":{"system":"sec-edgar","filing":"0001209191-17-050815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117050815/doc4.xml","form_type":"4"}},{"id":4580045,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":159602,"kind":"person","name":"Shames Richard S.","position":1,"cik":"0001675878","reported_name":"Shames Richard S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-13T20:32:31.000Z","date":"2016-10-11","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 48 equal monthly installments from the vesting commencement date of August 10, 2016."}],"balance_after":65000,"derivative":{"exercise_price":21.58,"expiration_date":"2026-10-11","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-16-145809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919116145809/doc4.xml","form_type":"4"}}]}